- Home
- AXSM vs TPH Comparison
AXSM vs TPH Comparison
Compare AXSM & TPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- TPH
- Stock Information
- Founded
- AXSM 2012
- TPH 2009
- Country
- AXSM United States
- TPH United States
- Employees
- AXSM N/A
- TPH N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- TPH Homebuilding
- Sector
- AXSM Health Care
- TPH Consumer Discretionary
- Exchange
- AXSM Nasdaq
- TPH Nasdaq
- Market Cap
- AXSM 4.0B
- TPH 4.0B
- IPO Year
- AXSM 2015
- TPH N/A
- Fundamental
- Price
- AXSM $93.19
- TPH $42.13
- Analyst Decision
- AXSM Strong Buy
- TPH Buy
- Analyst Count
- AXSM 14
- TPH 4
- Target Price
- AXSM $125.67
- TPH $48.00
- AVG Volume (30 Days)
- AXSM 427.1K
- TPH 683.7K
- Earning Date
- AXSM 11-04-2024
- TPH 10-24-2024
- Dividend Yield
- AXSM N/A
- TPH N/A
- EPS Growth
- AXSM N/A
- TPH N/A
- EPS
- AXSM N/A
- TPH 4.40
- Revenue
- AXSM $291,489,000.00
- TPH $4,192,540,000.00
- Revenue This Year
- AXSM $42.50
- TPH $19.37
- Revenue Next Year
- AXSM $69.28
- TPH $4.62
- P/E Ratio
- AXSM N/A
- TPH $9.58
- Revenue Growth
- AXSM 59.73
- TPH N/A
- 52 Week Low
- AXSM $55.02
- TPH $24.18
- 52 Week High
- AXSM $98.40
- TPH $47.78
- Technical
- Relative Strength Index (RSI)
- AXSM 64.50
- TPH 45.47
- Support Level
- AXSM $88.04
- TPH $42.10
- Resistance Level
- AXSM $97.00
- TPH $44.70
- Average True Range (ATR)
- AXSM 3.03
- TPH 1.13
- MACD
- AXSM 0.49
- TPH -0.21
- Stochastic Oscillator
- AXSM 64.58
- TPH 14.97
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company designs and builds single-family homes and condominiums through its portfolio of six regional housing brands. Its largest regional brands include Maracay Homes, which operates in Arizona, and TRI Pointe and Pardee Homes, which operate in California, Nevada, and Colorado. From a geographic perspective, California is TRI Pointe's largest source of revenue, followed by Arizona and Nevada. The company also operates in Texas, Oregon, and Virginia. TRI Pointe completes approximately 4,000 homes annually with an average selling price around $500,000. TRI Pointe also is involved in the sale and development of land.